Various copper and iron overload patterns in the livers of patients with Wilson disease and idiopathic copper toxicosis
Tóm tắt
Wilson disease (WD) is a major type of primary copper toxicosis associated with hypoceruloplasminemia, while idiopathic copper toxicosis (ICT) is a minor type characterized by normoceruloplasminemia. Because ceruloplasmin is the major circulating ferroxidase, iron metabolism may be affected in patients with WD. Biopsied liver specimens obtained from patients with primary copper toxicosis were fixed with glutaraldehyde solution and embedded in epoxy resin. Ultrathin sections that had or had not been stained with uranyl acetate solution were examined under an electron microscope equipped with an energy dispersive X-ray analyzer. A 7-year-old boy with WD was free from any metal overloading at the pre-treatment stage. Pre-treatment liver specimens of another 16 patients showed a variety of copper and iron overload patterns, from isolated copper to evenly distributed combined overloading. A 19-year-old female patient was free from any metal overloading after 7 years of treatment. Post-treatment overloading in another 6 patients ranged between evenly distributed combined patterns and isolated iron patterns. All patients had hypoceruloplasminemia throughout treatment periods. A patient with normoceruloplasminemic ICT continued to display isolated copper overloading after 2.5 years of treatment. In conclusion, these observations support the hypothesis that iron accumulates in patients with hypoceruloplasminemia.
Tài liệu tham khảo
Gitlin JD (2003) Wilson disease. Gastroenterology 125:1868–1877
Yamaguchi Y, Heiny ME, Gitlin JD (1993) Isolation and characterization of a human liver cDNA as a candidate gene for Wilson disease. Biochem Biophys Res Commun 197:271–277
Scheinberg IH, Sternlieb I (1994) Is non-Indian childhood cirrhosis caused by dietary copper? Lancet 344:1002–1004
Tanner MS, Portmann B, Mowat AP, Williams R, Pandit AN, Mills GF (1979) Increased hepatic copper concentration in Indian childhood cirrhosis. Lancet 1:1203–1205
Muller T, Feichtinger H, Berger H, Muller W (1996) Endemic Tyrolean infantile cirrhosis: an ecogenetic disorder. Lancet 347:877
Hanaichi T, Kidokoro R, Hayashi H, Sakamoto N (1984) Electron probe X-ray analysis on human hepatocellular lysosomes with copper deposits: copper binding to a thiol-protein in lysosomes. Lab Invest 51:592–597
Shiono Y, Wakusawa S, Hayashi H, Takikawa T, Yano M, Okada T, Mabuchi H, Kono S, Miyajima H (2001) Iron accumulation in the liver of male patients with Wilson’s disease. Am J Gastroenterol 96:3147–3151
Pietrangelo A (2007) Hemochromatosis: an endocrine liver disease. Hepatology 46:1291–1301
Nemeth E, Tuttle MS, Powelson J, Vaughn MB, Donovan A, Ward DM, Ganz T, Kaplan J (2004) Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science 306:2090–2093
Bridle KR, Frazer DM, Wilkins SJ, Dixon JL, Purdie DM, Crawford DH, Subramaniam VN, Powell LW, Anderson GL, Ramm GA (2003) Disrupted hepcidin regulation in HFE-associated haemochromatosis and the liver as a regulator of body iron homoeostasis. Lancet 361:669–673
Motonishi S, Hayashi H, Fujita Y, Okada T, Kusakabe A (2006) Copper- and iron-rich matrices in hepatocellular lipofuscin particles of a young male patient: diagnostic ultrastructures for Wilson disease. Ultrastruct Pathol 30:409–414
Hayashi H, Yano M, Fujita Y, Wakusawa S (2006) Compound overload of copper and iron in patients with Wilson’s disease. Med Mol Morphol 39:121–126
Hayashi H, Fujita Y, Tatsumi Y, Hattori A, Hayashi K, Katano Y, Wakusawa S, Yano M, Itoh M, Mizutani N, Goto H (2009) Special stain and X-ray probe microanalysis of livers with Wilson disease. Hepatol Res 39:563–568
Tatsumi Y, Shinohara T, Imoto M, Wakusawa S, Yano M, Hayashi K, Hattori A, Hayashi H, Shimizu A, Ichiki T, Nakashima S, Katano Y, Goto H (2011) Potential of the international scoring system for the diagnosis of Wilson disease to differentiate Japanese patients who need anti-copper treatment. Hepatol Res 41:887–896
Ferenci P, Caca K, Loudianos G, Mieli-Vergani G, Tanner S, Sternlieb I, Schilsky M, Cox D, Berr F (2003) Diagnosis and phenotypic classification of Wilson disease. Liver Int 23:139–142
Walshe JM, Cox DW (1998) Effect of treatment of Wilson’s disease on natural history of haemochromatosis. Lancet 352:112–113
Erhardt A, Hoffmann A, Hefter H, Haussinger D (2002) HFE gene mutations and iron metabolism in Wilson’s diease. Liver 22:474–478
Merryweather-Clarke AT, Pointon JJ, Shearman JD, Robson KJ (1997) Global prevalence of putative haemochromatosis mutations. J Med Genet 34:275–278
Roberts EA, Schilsky ML (2003) A practice guideline on Wilson disease. Hepatology 37:1475–1492
Osaki S, Johnson DA, Frieden E (1971) The mobilization of iron from the perfused mammalian liver by a serum copper enzyme ferroxidase. J Biol Chem 246:3018–3023
Attieh ZK, Mukhopadhyay CK, Seshadri V, Tripoulas NA, Fox PL (1999) Ceruloplasmin ferroxidase activity stimulates cellular iron uptake by a trivalent cation-specific transport mechanism. J Biol Chem 274:1116–1123
Miyajima H, Nishimura Y, Mizoguchi K, Sakamoto M, Shimizu T, Honda N (1987) Familial apoceruloplasmin deficiency associated with blepharospasm and retinal degeneration. Neurology 37:761–767
Goldfischer S, Sternlieb I (1968) Changes in the distribution of hepatic copper in relation to the progression of Wilson’s disease (hepatolenticular degeneration). Am J Pathol 53:883–901
Hayashi H, Piperno A, Tomosugi N, Hayashi K, Kimura F, Wakusawa S, Yano M, Tatsumi Y, Hattori A, Pelucchi S, Katano Y, Goto H (2010) Patients with chronic hepatitis C may be more sensitive to iron hepatotoxicity than patients with HFE-hemochromatosis. Intern Med 49:2371–2377
Hellman NE, Schaefer M, Gehrke S, Stegen P, Hoffman WJ, Gitlin JD, Stremmel W (2000) Hepatic iron overload in aceruloplasminemia. Gut 47:858–860
Mariani R, Arosio C, Pelucchi S, Grisoli M, Piga A, Trombini P, Piperno A (2004) Iron chelation therapy in aceruloplasminemia: study of a patient with a novel missense mutation. Gut 53:756–758